SRx Health Solutions Inc. (SRXH) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
SRx Health Solutions Inc. stock (SRXH) is currently trading at $0.12. SRx Health Solutions Inc. PS ratio (Price-to-Sales) is 3.86. WallStSmart rates SRXH as Sell.
- SRXH PE ratio analysis and historical PE chart
- SRXH PS ratio (Price-to-Sales) history and trend
- SRXH intrinsic value — DCF, Graham Number, EPV models
- SRXH stock price prediction 2025 2026 2027 2028 2029 2030
- SRXH fair value vs current price
- SRXH insider transactions and insider buying
- Is SRXH undervalued or overvalued?
- SRx Health Solutions Inc. financial analysis — revenue, earnings, cash flow
- SRXH Piotroski F-Score and Altman Z-Score
- SRXH analyst price target and Smart Rating
SRx Health Solutions Inc.
📊 No data available
Try selecting a different time range
Smart Analysis
SRx Health Solutions Inc. (SRXH) · 6 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Concerns around market cap and operating margin. Significant fundamental concerns warrant caution or avoidance.
SRx Health Solutions Inc. (SRXH) Key Strengths (0)
SRx Health Solutions Inc. (SRXH) Areas to Watch (6)
Losing money on operations
Revenue declining -9.40%, a shrinking business
Very expensive at 10.2x book value
Very low institutional interest at 0.18%
Micro-cap company with very limited liquidity and high volatility
Revenue is fairly priced at 3.86x sales
SRx Health Solutions Inc. (SRXH) Detailed Analysis Report
Overall Assessment
This company scores 14/100 in our Smart Analysis, earning a F grade. Out of 6 metrics analyzed, 0 register as strengths (avg 0/10) while 6 fall into concern territory (avg 2.2/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
Limited fundamental strengths were identified. The bull case requires improvement in core metrics.
The Bear Case
The primary concerns are Operating Margin, Revenue Growth, Price/Book. Some valuation metrics including Price/Sales (3.86), Price/Book (10.24) suggest expensive pricing. Growth concerns include Revenue Growth at -9.40%, which may limit upside. Profitability pressure is visible in Operating Margin at -135.00%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Operating Margin improves, as this is the primary drag on the overall score. Second, margin trajectory, with Operating Margin at -135.00% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -9.40% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Operating Margin and Revenue Growth are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
SRXH Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
SRXH's Price-to-Sales ratio of 3.86x sits near its historical average of 4.17x (0th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 20% below its historical high of 4.84x set in Mar 2026, and 0% above its historical low of 3.86x in Mar 2026.
WallStSmart Analysis Synopsis
Data-driven financial summary for SRx Health Solutions Inc. (SRXH) · CONSUMER DEFENSIVE › PACKAGED FOODS
The Big Picture
SRx Health Solutions Inc. operates as a stable business with moderate growth and solid fundamentals. Revenue reached 9M with 9% decline year-over-year. The company is currently unprofitable, posting a 0.0% profit margin.
Key Findings
Revenue contracted 9% YoY. Worth determining whether this is cyclical or structural.
Free cash flow is -11M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Sector dynamics: monitor PACKAGED FOODS industry trends, competitive moves, and regulatory changes that could impact SRx Health Solutions Inc..
Bottom Line
SRx Health Solutions Inc. offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Data sourced from SEC Form 4 filings
Last updated: 8:28:07 AM
About SRx Health Solutions Inc.(SRXH)
NYSE MKT
CONSUMER DEFENSIVE
PACKAGED FOODS
USA
SRx Health Solutions Inc. provides healthcare and medical treatment services.